Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 63 Records) |
Query Trace: Colorectal Neoplasms and ERCC1[original query] |
---|
[Validation of genetic polymorphisms associated to the toxicity of chemotherapy in colorectal cancer patients]. Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria 0 38 (4): 283-90. Cortejoso L, García M I, García-Alfonso P, Grávalos C, Robles L, González-Haba E, Sanjurjo M, López-Fernández L |
CYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients. Medical oncology (Northwood, London, England) 2014 Jul 31 (7): 72. Gil Justyna, Gaj Pawe?, Misiak B?a?ej, Ostrowski Jerzy, Karpinski Pawel, Jarczy?ska Alicja, Kielan Wojciech, Sasiadek Maria Malgorza |
Association of single nucleotide polymorphisms of ERCC1 and XPF with colorectal cancer risk and interaction with tobacco use. Gene 2014 Sep 548 (1): 1-5. Hou Ruizhi, Liu Yan, Feng Ye, Sun Libo, Shu Zhenbo, Zhao Jisheng, Yang Shuju |
Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population. Scientific reports 2014 4 4112. Ni Min, Zhang Wei-zhong, Qiu Jin-rong, Liu Fei, Li Min, Zhang Ya-jie, Liu Qing, Bai J |
Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. The pharmacogenomics journal 2015 Aug 15 (4): 354-62. Maus M K H, Hanna D L, Stephens C L, Astrow S H, Yang D, Grimminger P P, Loupakis F, Hsiang J H, Zeger G, Wakatsuki T, Barzi A, Lenz H |
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients. Scientific reports 2014 4 6828. Ruzzo Annamaria, Graziano Francesco, Galli Fabio, Giacomini Elisa, Floriani Irene, Galli Francesca, Rulli Eliana, Lonardi Sara, Ronzoni Monica, Massidda Bruno, Zagonel Vittorina, Pella Nicoletta, Mucciarini Claudia, Labianca Roberto, Ionta Maria Teresa, Veltri Enzo, Sozzi Pietro, Barni Sandro, Ricci Vincenzo, Foltran Luisa, Nicolini Mario, Biondi Edoardo, Bramati Annalisa, Turci Daniele, Lazzarelli Silvia, Verusio Claudio, Bergamo Francesca, Sobrero Alberto, Frontini Luciano, Magnani Mau |
The ERCC1 C118T polymorphism predicts clinical outcomes of colorectal cancer patients receiving oxaliplatin-based chemotherapy: a meta-analysis based on 22 studies. Asian Pacific journal of cancer prevention : APJCP 2014 15 (19): 8383-90. Qian Ying-Ying, Liu Xin-You, Wu Qian, Song Xian, Chen Xiao-Feng, Liu Yi-Qian, Pei Dong, Shen Li-Zong, Shu Yong-Qi |
AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin. The pharmacogenomics journal 2015 Aug . Kjersem J B, Thomsen M, Guren T, Hamfjord J, Carlsson G, Gustavsson B, Ikdahl T, Indrebø G, Pfeiffer P, Lingjærde O, Tveit K M, Wettergren Y, Kure E |
Association between the ERCC1 rs11615 polymorphism and clinical outcomes of oxaliplatin-based chemotherapies in gastrointestinal cancer: a meta-analysis. OncoTargets and therapy 2015 8 641-8. Ma Shou-Cheng, Zhao Yue, Zhang Tao, Ling Xiao-Ling, Zhao |
Association between ERCC1 and XPF polymorphisms and risk of colorectal cancer. Genetics and molecular research : GMR 2015 14 (1): 700-5. Yang H, Li G, Li W |
XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population. Mutagenesis 2015 May 30 (3): 441-9. Dai Qiong, Luo Hua, Li Xing Pu, Huang Juan, Zhou Tie Jun, Yang Zhi-H |
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis. Pharmacogenomics 2016 Sep . Shahnam Adel, Ridha Zainab, Wiese Michael D, Kichenadasse Ganessan, Sorich Michael |
The Contribution of Excision Repair Cross-complementing Group 1 Genotypes to Colorectal Cancer Susceptibility in Taiwan. Anticancer research 2017 05 37 (5): 2307-2313. Yueh Te-Cheng, Chou An-Kuo, Gong Chi-Li, Fu Chun-Kai, Pei Jen-Sheng, Wu Ming-Hsien, Tsai Chia-Wen, Chang Wen-Shin, Hsiao Chieh-Lun, Yen Shiou-Ting, Li Hsin-Ting, Bau DA-Ti |
Association of ERCC1 Polymorphisms with the Risk of Colorectal Cancer: A Meta-Analysis. Critical reviews in eukaryotic gene expression 2017 27 (3): 267-275. Chen Jianfeng, Sun Ningjie, Hu Gang, Chen Xiansheng, Jiang Jiansong, Wu Haiming, Luo Gaoji |
Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients. Cancer genetics 2017 Dec 218-219 51-57. Zhang Liping, Zhao Jiangman, Yu Bin, Song Xinjiang, Sun Guogang, Han Lijiang, Wang Lu, Dong S |
Polymorphisms of cancer-related genes and risk of multipleprimary malignancies involving colorectal cancer. Turkish journal of medical sciences 2017 11 47 (5): 1549-1554. Cao Peiguo, Yu Li, Wu Anshan, Li Jingjing, Liu Ling, Liu Chunlan, Zhou Jianda, Cao Ke, Guo Chengxi |
Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Nov . Abad A, Martínez-Balibrea E, Viéitez J M, Alonso-Orduña V, García Alfonso P, Manzano J L, Massutí B, Benavides M, Carrato A, Zanui M, Gallego J, Grávalos C, Conde V, Provencio M, Valladares-Ayerbes M, Salazar R, Sastre J, Montagut C, Rivera F, Aranda |
The polymorphisms of miRNA-binding site in MLH3 and ERCC1 were linked to the risk of colorectal cancer in a case-control study. Cancer medicine 2018 Mar . Zhang Qianye, Zheng Xiao, Li Xiaoxia, Sun Deyu, Xue Ping, Zhang Guopei, Xiao Mingyang, Cai Yuan, Jin Cuihong, Yang Jinghua, Wu Shengwen, Lu Xiao |
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin. Oncotarget 2019 10 10 (53): 5510-5522. Rao Devika, Mallick Atrayee Basu, Augustine Titto, Daroqui Cecilia, Jiffry Jeeshan, Merla Amartej, Chaudhary Imran, Seetharam Raviraja, Sood Arjun, Gajavelli Srikanth, Aparo Santiago, Rajdev Lakshmi, Kaubisch Andreas, Chuy Jennifer, Negassa Abdissa, Mariadason John M, Maitra Radhashree, Goel Sanj |
Association between nucleotide excision repair gene polymorphism and colorectal cancer risk. Journal of clinical laboratory analysis 2019 Sep e22956. Zhang Yujie, Wu Shenshen, Zhou Xiumei, Huang Fang, Chen Rui, Wang Yigang, Wu Jio |
Influence of ABCB-1, ERCC-1 and ERCC-2 gene polymorphisms on response to capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer (CRC) patients of South India. Journal of clinical pharmacy and therapeutics 2020 May . Varma Ashok, Mathaiyan Jayanthi, Shewade Deepak, Dubashi Biswajit, Sunitha Kodide |
Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival. BMC cancer 2020 May 20 (1): 409. Salimzadeh Hamideh, Lindskog Elinor Bexe, Gustavsson Bengt, Wettergren Yvonne, Ljungman Dav |
Expression of astrocyte-elevated gene-1 indicates prognostic value of fluoropyrimidine-based adjuvant chemotherapy in resectable stage III colorectal cancer. Pathology international 2021 9 71 (11): 752-764. Lin Long-Wei, Lai Peng-Sheng, Chen Ying-Yin, Chen Chung- |
Predictive value of KRAS mutation and excision repair cross-complementing 1 (ERCC1) protein overexpression in patients with colorectal cancer administered FOLFOX regimen. Asian journal of surgery 2021 Jan . Park Sun Min, Choi Sung Bong, Lee Yoon Suk, Lee In K |
Polymorphisms of nucleotide excision repair genes associated with colorectal cancer risk: Meta-analysis and trial sequential analysis. Frontiers in genetics 2022 11 13 1009938. Yi Chuncheng, Li Tiandong, Shen Yajing, Wang Peng, Dai Liping, Shi Jianxiang, Wang Keyan, Sun Changqing, Ye H |
Association between ERCC1 Gene Polymorphism (rs11615) and Colorectal Cancer Susceptibility: A Meta-Analysis of Medical Image Fusion and Safety Applications. Computational and mathematical methods in medicine 2022 2022 9988513. Liu Min, Qiu Zhifeng, Yang |
The role of heavy metals in the development of colorectal cancer. BMC cancer 2023 7 23 (1): 616. Yongsheng Li, Jingwei Lou, Shaozhong Hong, Dengfeng Hou, Yandong Lv, Zhiqiang Guo, Kai Wang, Yue Xu, Yufeng Zhai, Hongzhou L |
ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia. Genes 2023 7 14 (7): . Dhouha Jamai, Raja Gargouri, Boulbaba Selmi, Abdelmajid Khab |
Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer. International journal of molecular sciences 2024 1 25 (1): . Yasmin Cura, Almudena Sánchez-Martín, Noelia Márquez-Pete, Encarnación González-Flores, Fernando Martínez-Martínez, Cristina Pérez-Ramírez, Alberto Jiménez-Moral |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: